A detailed history of Deka Bank Deutsche Girozentrale transactions in Alector, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 100,000 shares of ALEC stock, worth $192,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100,000
Previous 100,000 -0.0%
Holding current value
$192,000
Previous $437,000 12.36%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 25, 2023

BUY
$5.86 - $7.93 $438,914 - $593,957
74,900 Added 298.41%
100,000 $584,000
Q1 2022

Apr 28, 2022

BUY
$13.02 - $20.78 $29,946 - $47,794
2,300 Added 10.09%
25,100 $364,000
Q4 2021

Feb 02, 2022

BUY
$19.35 - $25.54 $11,610 - $15,324
600 Added 2.7%
22,800 $484,000
Q3 2020

Oct 29, 2020

BUY
$10.54 - $24.96 $233,987 - $554,112
22,200 New
22,200 $233,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $159M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.